Parkinson Disease
Conditions
Keywords
Parkinson's Disease, Parkinson's
Brief summary
Historically, participation in clinical studies is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for Parkinson's Disease patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of Parkinson's Disease. The data collected from this study will help improve future outcomes for all Parkinson's Disease patients as well as those in under-represented demographic groups.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
50 Years to 80 Years
Inclusion criteria
* Patient plans to participate in an interventional clinical trial for the condition of Parkinson's Disease * Patient has been diagnosed with a type of Parkinson's Disease * Patient is at least 50 to 80 years of age * Patient has access to a home internet connection in order to provide regular updates through the course of the study
Exclusion criteria
* Patient has an ECOG score of 4 or higher * Patient is not able to provide consistent digital updates as per study requirements * Patient does not complete or agree to terms outlined in the Informed Consent Form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to enroll in an Parkinson's Disease clinical trial | 3 months |
| Rate of patients who remain in Parkinson's Disease clinical trial to trial completion | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed